// App-Quantinova.ai

THU0271 (2018) : Emergence of severe spondyloarthropathy related entheseal pathology following vedolizumab therapy for inflammatory bowel disease

Researchers

Presenter

  • S. Dubash

Principal Investigators

  • T. Marianayagam

  • T. Al-Araimi

  • C. Pagnoux

  • A. Weizman

  • M.-L. Tran Minh

  • M. Allez

  • P. Richette

  • H. Marzo-Ortega

  • D. McGonagle

Medical Centers

  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals

  • Rheumatology, East and North Hertfordshire NHS Trust, Stevenage, UK

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

  • Hopital Lariboisiere, University Hospitals Group, Paris, France

Locations

  • United Kingdom

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Inflammatory bowel disease

  • Spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved